Literature DB >> 15921489

Examples of implementation and evaluation of treatment fidelity in the BCC studies: where we are and where we need to go.

Barbara Resnick1, Albert J Bellg, Belinda Borrelli, Carol Defrancesco, Rosemary Breger, Jacki Hecht, Daryl L Sharp, Chantal Levesque, Denise Orwig, Denise Ernst, Gbenga Ogedegbe, Susan Czajkowski.   

Abstract

Treatment fidelity plays an important role in the research team's ability to ensure that a treatment has been implemented as intended and that the treatment has been accurately tested. Developing, implementing, and evaluating a treatment fidelity plan can be challenging. The treatment fidelity workgroup within the Behavior Change Consortium (BCC) developed guidelines to comprehensively evaluate treatment fidelity in behavior change research. The guidelines include evaluation of treatment fidelity with regard to study design, training of interventionists, delivery and receipt of the intervention, and enactment of the intervention in real-life settings. This article describes these guidelines and provides examples from four BCC studies as to how these recommended guidelines for fidelity were considered. Future work needs to focus not only on implementing treatment fidelity plans but also on quantifying the evaluations performed, developing specific criteria for interpretation of the findings, and establishing best practices of treatment fidelity.

Mesh:

Year:  2005        PMID: 15921489     DOI: 10.1207/s15324796abm2902s_8

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  51 in total

1.  Reporting implementation in randomized trials: proposed additions to the consolidated standards of reporting trials statement.

Authors:  Evan Mayo-Wilson
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

2.  The Assessment, Monitoring, and Enhancement of Treatment Fidelity In Public Health Clinical Trials.

Authors:  Belinda Borrelli
Journal:  J Public Health Dent       Date:  2011       Impact factor: 1.821

3.  Evaluating implementation fidelity in health information technology interventions.

Authors:  Eric L Eisenstein; David F Lobach; Paul Montgomery; Kensaku Kawamoto; Kevin J Anstrom
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

4.  Development of a Tailored Behavioral Weight Loss Program for Veterans With PTSD (MOVE!+UP): A Mixed-Methods Uncontrolled Iterative Pilot Study.

Authors:  Katherine D Hoerster; Lamont Tanksley; Tracy Simpson; Brian E Saelens; Jürgen Unützer; Marissa Black; Preston Greene; Nadiyah Sulayman; Gayle Reiber; Karin Nelson
Journal:  Am J Health Promot       Date:  2020-03-12

5.  Comparison of intervention fidelity between COPE TEEN and an attention-control program in a randomized controlled trial.

Authors:  Stephanie A Kelly; Krista Oswalt; Bernadette Mazurek Melnyk; Diana Jacobson
Journal:  Health Educ Res       Date:  2014-10-29

6.  Consideration of treatment fidelity to improve manual therapy research.

Authors:  Steve Karas; Laura Plankis
Journal:  J Man Manip Ther       Date:  2016-09

7.  Strategies used and data obtained during treatment fidelity monitoring.

Authors:  Janet S Carpenter; Debra S Burns; Jingwei Wu; Menggang Yu; Kristin Ryker; Eileen Tallman; Diane Von Ah
Journal:  Nurs Res       Date:  2013 Jan-Feb       Impact factor: 2.381

8.  Group prenatal care: model fidelity and outcomes.

Authors:  Gina Novick; Allecia E Reid; Jessica Lewis; Trace S Kershaw; Sharon Schindler Rising; Jeannette R Ickovics
Journal:  Am J Obstet Gynecol       Date:  2013-03-21       Impact factor: 8.661

9.  Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence.

Authors:  Paul F Cook; Robert W Bremer; A J Ayala; Malik Y Kahook
Journal:  Clin Ophthalmol       Date:  2010-10-05

10.  B.A.I.L.A. - a Latin dance randomized controlled trial for older Spanish-speaking Latinos: rationale, design, and methods.

Authors:  David X Marquez; JoEllen Wilbur; Susan L Hughes; Michael L Berbaum; Robert S Wilson; David M Buchner; Edward McAuley
Journal:  Contemp Clin Trials       Date:  2014-06-24       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.